Literature DB >> 28944421

Metabolic abnormalities in rheumatoid arthritis patients with comorbid diabetes mellitus.

Xing Zhen Liu1,2, Ying Gao1, Jie Fan2, Xia Xu1, Ju Zhang1, Jie Gao1, Wei Wan1, Dong Bao Zhao3.   

Abstract

The metabolic characteristics of rheumatoid arthritis (RA) or diabetes mellitus (DM) have been studied, but the metabolic abnormalities of RA patients complicated with DM are not completely understood. Therefore, we recruited RA patients with DM to investigate the metabolic abnormalities in these patients. We collected data of RA patients with DM and age- and sex-matched RA and DM patients from Changhai Hospital's electronic medical record system. Data of demographically matched healthy controls were also collected from the health management system of the Hangzhou Sanatorium of People's Liberation Army. Blood pressure, uric acid, glucose, and lipid levels were compared. The clinical data of RA with DM (n = 104), DM (n = 100), and RA (n = 100) patients and healthy controls (n = 100) were collected and compared. RA patients with DM had higher blood pressure and lower high-density lipoprotein cholesterol levels than the other three groups, a higher triglycerides (TG) level than healthy controls and RA patients, and a lower TG level than DM patients. RA patients with DM exhibited a relatively high proportion of metabolic abnormalities based on existing standards. Our study examined metabolic abnormalities in RA patients with DM for the first time, and our results suggest that clinicians should pay more attention to the metabolic abnormalities of RA patients with DM.

Entities:  

Keywords:  Cardiovascular disease; Diabetes; Dyslipidemia; Rheumatoid arthritis

Mesh:

Substances:

Year:  2017        PMID: 28944421     DOI: 10.1007/s10067-017-3847-7

Source DB:  PubMed          Journal:  Clin Rheumatol        ISSN: 0770-3198            Impact factor:   2.980


  38 in total

1.  Influence of glucocorticoids and disease activity on total and high density lipoprotein cholesterol in patients with rheumatoid arthritis.

Authors:  M Boers; M T Nurmohamed; C J A Doelman; L R Lard; A C Verhoeven; A E Voskuyl; T W J Huizinga; R J van de Stadt; B A C Dijkmans; Sj van der Linden
Journal:  Ann Rheum Dis       Date:  2003-09       Impact factor: 19.103

2.  Lipid testing in patients with rheumatoid arthritis and key cardiovascular-related comorbidities: a medicare analysis.

Authors:  Christie M Bartels; Amy J H Kind; Carolyn T Thorpe; Christine M Everett; Rachel J Cook; Patrick E McBride; Maureen A Smith
Journal:  Semin Arthritis Rheum       Date:  2012-03-16       Impact factor: 5.532

3.  Performance of four current risk algorithms in predicting cardiovascular events in patients with early rheumatoid arthritis.

Authors:  E E A Arts; C Popa; A A Den Broeder; A G Semb; T Toms; G D Kitas; P L van Riel; J Fransen
Journal:  Ann Rheum Dis       Date:  2014-01-03       Impact factor: 19.103

4.  Usefulness of risk scores to estimate the risk of cardiovascular disease in patients with rheumatoid arthritis.

Authors:  Cynthia S Crowson; Eric L Matteson; Veronique L Roger; Terry M Therneau; Sherine E Gabriel
Journal:  Am J Cardiol       Date:  2012-04-20       Impact factor: 2.778

Review 5.  Novel risk factors for cardiovascular disease in rheumatoid arthritis.

Authors:  Jenny Amaya-Amaya; Juan Camilo Sarmiento-Monroy; Ruben-Dario Mantilla; Ricardo Pineda-Tamayo; Adriana Rojas-Villarraga; Juan-Manuel Anaya
Journal:  Immunol Res       Date:  2013-07       Impact factor: 2.829

Review 6.  Cardiovascular comorbidity in rheumatic diseases.

Authors:  Michael T Nurmohamed; Maaike Heslinga; George D Kitas
Journal:  Nat Rev Rheumatol       Date:  2015-08-18       Impact factor: 20.543

7.  Trial of Atorvastatin in Rheumatoid Arthritis (TARA): double-blind, randomised placebo-controlled trial.

Authors:  David W McCarey; Iain B McInnes; Rajan Madhok; Rosie Hampson; Olga Scherbakov; Ian Ford; Hilary A Capell; Naveed Sattar
Journal:  Lancet       Date:  2004-06-19       Impact factor: 79.321

8.  Does rheumatoid arthritis equal diabetes mellitus as an independent risk factor for cardiovascular disease? A prospective study.

Authors:  Mike J L Peters; Vokko P van Halm; Alexandre E Voskuyl; Yvo M Smulders; Maarten Boers; Willem F Lems; Marjolein Visser; Coen D A Stehouwer; Jacqueline M Dekker; Giel Nijpels; Rob Heine; Ben A C Dijkmans; Michael T Nurmohamed
Journal:  Arthritis Rheum       Date:  2009-11-15

9.  Beyond Body Mass Index: Advantages of Abdominal Measurements for Recognizing Cardiometabolic Disorders.

Authors:  Henry S Kahn; Kai McKeever Bullard
Journal:  Am J Med       Date:  2015-08-21       Impact factor: 4.965

Review 10.  Predicting cardiometabolic risk: waist-to-height ratio or BMI. A meta-analysis.

Authors:  Savvas C Savva; Demetris Lamnisos; Anthony G Kafatos
Journal:  Diabetes Metab Syndr Obes       Date:  2013-10-24       Impact factor: 3.168

View more
  3 in total

Review 1.  Hypertension in connective tissue disease.

Authors:  Qiang Luo; Yiwen Zhang; Xiaoqian Yang; Li Qin; Han Wang
Journal:  J Hum Hypertens       Date:  2022-05-03       Impact factor: 3.012

Review 2.  Mechanistic and therapeutic links between rheumatoid arthritis and diabetes mellitus.

Authors:  Jing Li; Yazhuo Chen; Qingyun Liu; Zhufang Tian; Yan Zhang
Journal:  Clin Exp Med       Date:  2022-03-20       Impact factor: 3.984

3.  Dose-response associations between metabolic indexes and the risk of comorbid type 2 diabetes mellitus among rheumatoid arthritis patients from Northern China: a case-control study.

Authors:  Guangxiao Li; Weijun Chi; Bingqing Bai; Ying Li; Tingting Wei; Lingyu Fu
Journal:  BMJ Open       Date:  2019-07-04       Impact factor: 2.692

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.